[1] SHETH NP, ROZELL JC,PAPROSKY WG. Evaluation and Treatment of Patients With Acetabular Osteolysis After Total Hip Arthroplasty. J Am Acad Orthop Surg. 2019;27(6):e258-e267.
[2] KURTZ S, ONG K, LAU E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780-785.
[3] MAHOMED NN, BARRETT JA, KATZ JN, et al. Rates and outcomes of primary and revision total hip replacement in the United States medicare population. J Bone Joint Surg Am. 2003;85(1):27-32.
[4] ONG KL, LAU E, SUGGS J, et al. Risk of subsequent revision after primary and revision total joint arthroplasty. Clin Orthop Relat Res. 2010;468(11):3070-3076.
[5] SCHWARTZ AM, FARLEY KX, GUILD GN, et al. Projections and Epidemiology of Revision Hip and Knee Arthroplasty in the United States to 2030. J Arthroplasty. 2020;35(6S):S79-S85.
[6] GOODMAN SB, MA T. Cellular chemotaxis induced by wear particles from joint replacements. Biomaterials. 2010;31(19): 5045-5050.
[7] OLLIVERE B, WIMHURST JA, CLARK IM, et al. Current concepts in osteolysis. J Bone Joint Surg Br. 2012;94(1):10-15.
[8] BITAR D, PARVIZI J. Biological response to prosthetic debris. World J Orthop. 2015;6(2):172-189.
[9] HOLT G, MURNAGHAN C, REILLY J, et al. The biology of aseptic osteolysis. Clin Orthop Relat Res. 2007;460:240-252.
[10] HODGES NA, SUSSMAN EM, STEGEMANN JP. Aseptic and septic prosthetic joint loosening: Impact of biomaterial wear on immune cell function, inflammation, and infection. Biomaterials. 2021;278:121127.
[11] LI Y, LING J, JIANG Q. Inflammasomes in Alveolar Bone Loss. Front Immunol. 2021;12:691013.
[12] NEJAT N, VALDIANI A, CAHILL D, et al. Ornamental exterior versus therapeutic interior of Madagascar periwinkle (Catharanthus roseus): the two faces of a versatile herb. ScientificWorldJournal. 2015;2015: 982412.
[13] QU Y, EASSON ML, FROESE J, et al. Completion of the seven-step pathway from tabersonine to the anticancer drug precursor vindoline and its assembly in yeast. Proc Natl Acad Sci U S A. 2015;112(19): 6224-6229.
[14] ZHANG D, LI X, HU Y, et al. Tabersonine attenuates lipopolysaccharide-induced acute lung injury via suppressing TRAF6 ubiquitination. Biochem Pharmacol. 2018;154:183-192.
[15] DAI C, LUO W, CHEN Y, et al. Tabersonine attenuates Angiotensin II-induced cardiac remodeling and dysfunction through targeting TAK1 and inhibiting TAK1-mediated cardiac inflammation. Phytomedicine. 2022;103:154238.
[16] 张云鸽,宋科官.假体周围磨损颗粒诱导骨溶解:钙调磷酸酶/活化T细胞核因子信号通路作用的研究进展[J].中国组织工程研究, 2017;21(7):1115-1122.
[17] SUN KY, WU Y, XU J, et al. Niobium carbide (MXene) reduces UHMWPE particle-induced osteolysis. Bioact Mater. 2022;8:435-448.
[18] CALLAGHAN JJ, HENNESSY DW, LIU SS, et al. Cementing acetabular liners into secure cementless shells for polyethylene wear provides durable mid-term fixation. Clin Orthop Relat Res. 2012;470(11): 3142-3147.
[19] LU Y, XU X, YANG C, et al. Copper modified cobalt-chromium particles for attenuating wear particle induced-inflammation and osteoclastogenesis. Biomater Adv. 2023;147:213315.
[20] YIN J, YIN Z, LAI P, et al. Pyroptosis in Periprosthetic Osteolysis. Biomolecules. 2022;12(12):1733.
[21] ZHAO F, CANG D, ZHANG J, et al. Chemerin/ChemR23 signaling mediates the effects of ultra-high molecular weight polyethylene wear particles on the balance between osteoblast and osteoclast differentiation. Ann Transl Med. 2021;9(14):1149.
[22] FERREIRA P, BATES P, DAOUB A, et al. Is bisphosphonate use a risk factor for atypical periprosthetic/peri-implant fractures? - A metanalysis of retrospective cohort studies and systematic review of the current evidence. Orthop Traumatol Surg Res. 2023;109(2):103475.
[23] FIORILLO L, CICCIU M, TOZUM TF, et al. Impact of bisphosphonate drugs on dental implant healing and peri-implant hard and soft tissues: a systematic review. BMC Oral Health. 2022;22(1):291.
[24] KAWAHARA M, KUROSHIMA S, SAWASE T. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review. Int J Implant Dent. 2021;7(1):47.
[25] QIAN C, WANG J, LIN W, et al. Tabersonine attenuates obesity-induced renal injury via inhibiting NF-kappaB-mediated inflammation. Phytother Res. 2023. doi: 10.1002/ptr.7756.
[26] SHI J, WANG C, SANG C, et al. Tabersonine Inhibits the Lipopolysaccharide-Induced Neuroinflammatory Response in BV2 Microglia Cells via the NF-kappaB Signaling Pathway. Molecules. 2022; 27(21):7521.
[27] SUN X, GAN L, LI N, et al. Tabersonine ameliorates osteoblast apoptosis in rats with dexamethasone-induced osteoporosis by regulating the Nrf2/ROS/Bax signalling pathway. AMB Express. 2020;10(1):165.
[28] XU HW, LI WF, HONG SS, et al. Tabersonine, a natural NLRP3 inhibitor, suppresses inflammasome activation in macrophages and attenuate NLRP3-driven diseases in mice. Acta Pharmacol Sin. 2023. doi: 10.1038/s41401-022-01040-z.
[29] KIM JM, LIN C, STAVRE Z, et al. Osteoblast-Osteoclast Communication and Bone Homeostasis. Cells. 2020;9(9):2073.
[30] 谢冰洁,冯捷,韩向龙.破骨细胞生物学特征的研究与进展[J].中国组织工程研究,2017,21(11):1770-1775.
[31] YAO Y, CAI X, REN F, et al. The Macrophage-Osteoclast Axis in Osteoimmunity and Osteo-Related Diseases. Front Immunol. 2021;12: 664871.
[32] WEI L, CHEN W, HUANG L, et al. Alpinetin ameliorates bone loss in LPS-induced inflammation osteolysis via ROS mediated P38/PI3K signaling pathway. Pharmacol Res. 2022;184:106400.
[33] WEN Z, LIN S, LI C, et al. MiR-92a/KLF4/p110delta regulates titanium particles-induced macrophages inflammation and osteolysis. Cell Death Discov. 2022;8(1):197.
[34] HU X, PING Z, GAN M, et al. Theaflavin-3,3’-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway. Acta Biomater. 2017;48:479-488.
[35] PING Z, WANG Z, SHI J, et al. Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-kappaB signaling. Acta Biomater. 2017;62:362-371.
[36] GREEN JM, HALLAB NJ, LIAO YS, et al. Anti-oxidation treatment of ultra high molecular weight polyethylene components to decrease periprosthetic osteolysis: evaluation of osteolytic and osteogenic properties of wear debris particles in a murine calvaria model. Curr Rheumatol Rep. 2013;15(5):325. |